References
Bright J, Khar A. Apoptosis: programmed cell death in health and disease. Biosci Res 1994; 14: 67–81.
Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456–1462.
Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell 1994; 76: 1–3.
Martin SJ, Green DG. Protease activation during apoptosis: death by a thousand cuts? Cell 1995; 82: 349–352.
Berke G. The CTL's kiss of death. Cell 1995; 81: 9–12.
Smyth MJ, Trapani JA. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 1995; 16: 202–206.
Quan LT, Tewari M, O'Rourke K, et al. Proteolytic activation of the cell death protease YAMA/CPP32 by granzyme B. Proc Natl Acad Sci USA 1996; 93: 1972–1976.
Duan H, Orth K, Chinnaiyan AM, et al. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J Biol Chem 1996; 271: 16720–16724.
Smith CA, Farrah T, Goodwin RG. The TNF receptor super-family of cellular and viral proteins: activation, costimulation, and death. Cell 1994; 76: 959–963.
Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/Apo-1-and TNF receptor-induced cell death. Cell 1996; 85: 803–815.
Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85: 817–827.
Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15: 7–10.
Gill BM, Nishikata H, Chan G, Delovitch TL, Ochi A. Fas antigen and sphingomyelin-ceramide turnover-mediated signaling: role in life and death of T lymphocytes. Immunol Rev 1994; 142: 113–125.
Susin SA, Zamzami N, Kroemer G. The cell biology of apoptosis. Evidence for the implication of mitochondria. Apoptosis 1996; 1: 231–242.
Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood 1996; 88: 386–401.
Hawkins CJ, Vaux DL. Analysis of the role of bcl-2 in apoptosis. Immunol Rev 1994; 142: 127–139.
Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995; 16: 39–43.
Bernard G, Zoccola D, Deckert M, Breittmayer JP, Aussel C, Bernard A. The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4+CD8+ thymocytes. J Immunol 1995; 154: 26–32.
Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995; 16: 569–574.
Critchfield JM. T cell receptor specific apoptosis: an endogenous mechanism for T cell homeostasis and potential strategy for antigen modulation of disease. Apoptosis 1996; 1: 247–251.
Lynch DH. FasL and TNF interactions: their roles in immunoregulation and disease. Apoptosis 1996; 1: 243–246.
Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630–632.
Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189–1192.
Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 1996; 5: 7–16.
Süss G, Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 1996; 183: 1789–1796.
O'Connel J, O'Sullivan GC, Collins JK, Shanahan F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996; 184: 1075–1082.
Fisher G, Rosenberg FJ, Straus S, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935–946.
Knipping E, Krammer PH, Onel KB, Lehman TJA, Mysler E, Elkon KB. Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis. Arthritis Rheum 1995; 38: 1735–1737.
Green DR, Mahboubi A, Nishioka W, et al. Promotion and inhibition of activation-induced apoptosis in T-cell hybridomas by oncogenes and related signals. Immunol Rev 1994; 142: 321–342.
Halicka HD, Seiter K, Feldman EJ, et al. Cell cycle specificity of apoptosis during treatment of leukemias. Apoptosis (in press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malejczyk, J., Górski, A. Editorial review: Apoptosis and its role in immunity. Apoptosis 1, 227–230 (1996). https://doi.org/10.1007/BF00143315
Issue Date:
DOI: https://doi.org/10.1007/BF00143315